Secondary interventions · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in secondary interventions compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Major surgical complications · Percutaneous nephrolithotomy
Systemic TXA probably leads to lower major surgical complications compared with no TXA (placebo or usual care) (moderate certainty).
1 finding from 1 review
Minor surgical complications · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in minor surgical complications compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Unplanned hospitalizations or readmissions · Percutaneous nephrolithotomy
It is very uncertain whether systemic TXA changes unplanned hospitalizations or readmissions compared with no TXA (placebo or usual care) (very low certainty).
1 finding from 1 review
Length of hospital stay · Percutaneous nephrolithotomy
1 finding from 1 review
Treatment success rate · people (>14 years) with kidney stones
ESWL may leads to lower treatment success rate at 3 months MCID: 5% absolute difference compared with PCNL (low certainty).
1 finding from 1 review
Retreatment · people (>14 years) with kidney stones
ESWL probably leads to higher retreatment rate MCID: 3% absolute difference compared with RIRS (moderate certainty).
1 finding from 1 review
Auxiliary procedures rate MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL may leads to higher auxiliary procedures rate MCID: 3% absolute difference compared with RIRS (low certainty).
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · people (>14 years) with kidney stones
1 finding from 1 review
Quality of life Assumed MCID: NA · people (>14 years) with kidney stones
1 finding from 1 review
Complications MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL probably leads to lower complications MCID: 3% absolute difference compared with PCNL (moderate certainty).
1 finding from 1 review
Retreatment · people (>14 years) with kidney stones
ESWL may leads to higher retreatment rate MCID: 3% absolute difference compared with PCNL (low certainty).
1 finding from 1 review
Auxiliary procedures rate MCID: 3% absolute difference · people (>14 years) with kidney stones
ESWL probably leads to higher auxiliary procedures rate MCID: 3% absolute difference compared with PCNL (moderate certainty).
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · people (>14 years) with kidney stones
1 finding from 1 review
Treatment success rate · people (>14 years) with kidney stones
ESWL may leads to lower treatment success rate at 3 months MCID: 5% absolute difference compared with RIRS (low certainty).
1 finding from 1 review
Quality of life MCID varies by instrument. · people (>14 years) with kidney stones
1 finding from 1 review
Complications MCID: 3% absolute difference · people (>14 years) with kidney stones
It is very uncertain whether ESWL changes complications MCID: 3% absolute difference compared with RIRS (very low certainty).
1 finding from 1 review
Severe adverse events MCID: 50 per 1000 · treating kidney stones
It is very uncertain whether tubeless PNL changes severe adverse events MCID: 50 per 1000 compared with standard PNL (very low certainty).
1 finding from 1 review
Operating time · treating kidney stones
1 finding from 1 review
Length of hospital stay · treating kidney stones
1 finding from 1 review